X

We aim to transform protein production to allow universal access to biologics.

AREAS OF FOCUS

Animal Health

20 years’ experience in the development and production of animal vaccines.
200 molecules successfully produced in collaboration with public and private partners, including multiple international pharmaceutical companies.
FatrovaxRHD, first vaccine produced in CrisBio® received marketing authorization in the European Union and United Kingdom in Q3.

Learn more

Human Health

Building on experience in animal health, Algenex is expanding the production of proteins into human health to fully exploit the potential of its technology platforms

Learn more

Biocomponents

Algenex has an established track record as a producer of antigens proteins for the human and animal diagnostic and therapeutic markets and has also demonstrated the applicability of its technology platform CrisBio® to on-demand production of growth factors, enzymes and cytokines.

Learn more

LATEST NEWS

News

19/04
Company Technology

La Agencia Espa√Īola del Medicamento concede a Algenex la cer...

Sede de la Agencia Espa√Īola del Medicamento y Productos Sanitarios
Learn more

News

23/03
Company CrisBio

Algenex amplía su presencia en el mercado de la tecnología a...

Algenex amplía su presencia en el mercado de la Food Tech
Learn more

News

26/01
Company

Ofertas de trabajo en el √Ārea de Calidad

Creers: be part of Algenex story
Learn more